By Karen Bernstein

Alza Corp.'s spin-off of Therapeutic Discovery Corp. to its shareholders, which is structured much like an R&D partnership without the partners, could provide a model for product development funding by other biotech companies, once they achieve earnings and have significant amounts of cash in the bank.